SOHM, Inc. (SHMN)

Market Cap	2.13M -28.6%
Revenue (ttm)	1.30M +115.2%
Net Income	-1.13M
EPS	-0.00
Shares Out	2.90B
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	48,650
Open	0.0007
Previous Close	0.000735
Day's Range	0.0007 - 0.0008
52-Week Range	0.0006 - 0.0015
Beta	1.17
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About SOHM, Inc.

SOHM, Inc. develops, manufactures, markets, and distributes generic and private label pharmaceutical products in the United States. The company offers analgesics, antibiotics, anti-cold, and anti-inflammatory drugs, as well as over-the-counter, cosmeceuticals, and nutraceutical products. It also exports its products. The company has collaboration agreement with Coastar Therapeutics to advance in the field of genome editing using red blood cell membrane derived carriers and genome editing technology. SOHM, Inc. was founded in 2005 and is based i...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2005
• Employees: 145
• Stock Exchange: OTCMKTS
• Ticker Symbol: SHMN

Financial Performance

In 2012, SOHM, Inc.'s revenue was $1.30 million, a decrease of -3.27% compared to the previous year's $1.34 million. Losses were -$1.13 million, 106.1% more than in 2011.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Nov 7, 2026

Data Sources Report a data error